SuperworthProcessa Pharmaceuticals shares outstanding PCSA
Diluted shares outstanding, averaged over each quarter, from 2012.
- Latest quarter, to Jun 30, 2026
- 2.8M
- On a year earlier
- +337.5%
- more shares
Processa Pharmaceuticals had 2.8M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 337.5% more than a year earlier, so each share owns a little less of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 2.2M | +1481% |
| FY2024 | 140.3K | +149% |
| FY2023 | 56.3K | +71% |
| FY2022 | 32.9K | +5% |
| FY2021 | 31.5K | +18% |
| FY2020 | 26.7K | +142% |
| FY2019 | 11K | −0% |
| FY2018 | 11K | +10% |
| FY2017 | 10K | +11% |
| FY2016 | 9.1K | +1917% |
| FY2015 | 450 | +7% |
| FY2014 | 421 | +28% |
| FY2013 | 330 | +340% |
| FY2012 | 75 | n/a |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 2.8M | +337% | |
| Q1 FY26 | 2.6M | +601% | |
| Q4 FY25 | 2.2M | +1481% | |
| Q3 FY25 | 1.9M | +1351% | |
| Q2 FY25 | 628.8K | +427% | |
| Q1 FY25 | 374K | +279% | |
| Q4 FY24 | 140.3K | +149% | |
| Q3 FY24 | 131K | +143% | |
| Q2 FY24 | 119.3K | +122% | |
| Q1 FY24 | 98.7K | +117% | |
| Q4 FY23 | 56.3K | +71% | |
| Q3 FY23 | 54K | +67% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Processa Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.